Acacia Research Corp.'s CombiMatrix Awarded New US Air Force Contract to Advance Influenza-Detection System

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq:CBMX) (Nasdaq:ACTG) announced today that its CombiMatrix group has been awarded a new contract worth $869,000 by the Air Force Research Laboratory to advance its Influenza Genotyping System. The field-deployable system is based upon the company’s CustomArray™ microarray platform and ElectraSense™ detection technologies. The system can provide the user with a compact and rugged analyzer that can identify H5N1 bird flu as well as all human strains of influenza A and various other upper-respiratory pathogens of interest.

MORE ON THIS TOPIC